189 related articles for article (PubMed ID: 7881106)
1. Metabolism of breast cancer cells as revealed by non-invasive magnetic resonance spectroscopy studies.
Kaplan O; Cohen JS
Breast Cancer Res Treat; 1994; 31(2-3):285-99. PubMed ID: 7881106
[TBL] [Abstract][Full Text] [Related]
2. Application of NMR spectroscopy in biochemical studies of tumor cells sensitive and resistant to anticancer drugs.
Hanusovská E; Dovinová I; Tkác I; Novotný L
Neoplasma; 1998; 45(4):187-97. PubMed ID: 9890660
[TBL] [Abstract][Full Text] [Related]
3. Comparison of action of the anti-neoplastic drug lonidamine on drug-sensitive and drug-resistant human breast cancer cells: 31P and 13C nuclear magnetic resonance studies.
Vivi A; Tassini M; Ben-Horin H; Navon G; Kaplan O
Breast Cancer Res Treat; 1997 Mar; 43(1):15-25. PubMed ID: 9065595
[TBL] [Abstract][Full Text] [Related]
4. Phospholipid and energy metabolism of cancer cells monitored by 31P magnetic resonance spectroscopy: possible clinical significance.
Cohen JS
Mayo Clin Proc; 1988 Dec; 63(12):1199-207. PubMed ID: 3059078
[TBL] [Abstract][Full Text] [Related]
5. Monitoring the transport and phosphorylation of 2-deoxy-D-glucose in tumor cells in vivo and in vitro by 13C nuclear magnetic resonance spectroscopy.
Navon G; Lyon RC; Kaplan O; Cohen JS
FEBS Lett; 1989 Apr; 247(1):86-90. PubMed ID: 2707452
[TBL] [Abstract][Full Text] [Related]
6. Non-invasive assessment of tumor oxygenation status by integrated 31P NMR spectroscopy and 1H NMR imaging.
Rofstad EK; Lyng H; Olsen DR; Steinsland E
Adv Exp Med Biol; 1994; 345():531-8. PubMed ID: 8079755
[No Abstract] [Full Text] [Related]
7. Information from combined 1H and 31P NMR studies of cell extracts: differences in metabolism between drug-sensitive and drug-resistant MCF-7 human breast cancer cells.
Kaplan O; van Zijl PC; Cohen JS
Biochem Biophys Res Commun; 1990 Jun; 169(2):383-90. PubMed ID: 2357212
[TBL] [Abstract][Full Text] [Related]
8. Characterization of multidrug resistance and monitoring of tumor response by combined 31P and 1H nuclear magnetic resonance spectroscopic analysis.
Venkatesan PV; Saravanan K; Nagarajan B
Anticancer Drugs; 1998 Jun; 9(5):449-56. PubMed ID: 9660543
[TBL] [Abstract][Full Text] [Related]
9. Multinuclear NMR study of the metabolism of drug-sensitive and drug-resistant human breast cancer cells.
Cohen JS; Lyon RC
Ann N Y Acad Sci; 1987; 508():216-28. PubMed ID: 3439702
[No Abstract] [Full Text] [Related]
10. Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.
Kaplan O; Navon G; Lyon RC; Faustino PJ; Straka EJ; Cohen JS
Cancer Res; 1990 Feb; 50(3):544-51. PubMed ID: 2297696
[TBL] [Abstract][Full Text] [Related]
11. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G
Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445
[TBL] [Abstract][Full Text] [Related]
12. Creatine and cyclocreatine treatment of human colon adenocarcinoma xenografts: 31P and 1H magnetic resonance spectroscopic studies.
Kristensen CA; Askenasy N; Jain RK; Koretsky AP
Br J Cancer; 1999 Jan; 79(2):278-85. PubMed ID: 9888469
[TBL] [Abstract][Full Text] [Related]
13. In vivo studies by magnetic resonance imaging and spectroscopy of the response to tamoxifen of MCF7 human breast cancer implanted in nude mice.
Furman E; Margalit R; Bendel P; Horowitz A; Degani H
Cancer Commun; 1991 Sep; 3(9):287-97. PubMed ID: 1911045
[TBL] [Abstract][Full Text] [Related]
14. A versatile multinuclear probe designed for in vivo NMR spectroscopy: applications to subcutaneous human tumors in mice.
Lyon RC; Tschudin RG; Daly PF; Cohen JS
Magn Reson Med; 1988 Jan; 6(1):1-14. PubMed ID: 3352500
[TBL] [Abstract][Full Text] [Related]
15. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on 17 beta-estradiol-induced glucose metabolism in MCF-7 human breast cancer cells: 13C nuclear magnetic resonance spectroscopy studies.
Narasimhan TR; Safe S; Williams HJ; Scott AI
Mol Pharmacol; 1991 Dec; 40(6):1029-35. PubMed ID: 1758438
[TBL] [Abstract][Full Text] [Related]
16. Levels of phospholipid metabolites in breast cancer cells treated with antimitotic drugs: a 31P-magnetic resonance spectroscopy study.
Sterin M; Cohen JS; Mardor Y; Berman E; Ringel I
Cancer Res; 2001 Oct; 61(20):7536-43. PubMed ID: 11606391
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen withdrawal on energy-rich phosphates and prediction of estrogen dependence monitored by in vivo 31P magnetic resonance spectroscopy of four human breast cancer xenografts.
Kristensen CA; Kristjansen PE; Brünner N; Clarke R; Spang-Thomsen M; Quistorff B
Cancer Res; 1995 Apr; 55(8):1664-9. PubMed ID: 7712472
[TBL] [Abstract][Full Text] [Related]
18. Effect of glucose and confluency on phosphorus metabolites of perfused human prostatic adenocarcinoma cells as determined by 31P MRS.
Macdonald JM; Kurhanewicz J; Dahiya R; Espanol MT; Chang LH; Goldberg B; James TL; Narayan P
Magn Reson Med; 1993 Feb; 29(2):244-8. PubMed ID: 8429789
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the antineoplastic drug lonidamine: 31P and 13C nuclear magnetic resonance studies.
Ben-Horin H; Tassini M; Vivi A; Navon G; Kaplan O
Cancer Res; 1995 Jul; 55(13):2814-21. PubMed ID: 7796408
[TBL] [Abstract][Full Text] [Related]
20. Tamoxifen induced changes in MCF7 human breast cancer: in vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging.
Furman E; Rushkin E; Margalit R; Bendel P; Degani H
J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):189-95. PubMed ID: 1525059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
